Author | Karim Fizazi, MD, PhD | OncLive

Author | Karim Fizazi, MD, PhD

Articles

Dr. Fizazi Discusses Updated Data With Darolutamide in CRPC

June 13, 2019

Video

Karim Fizazi, MD, PhD, head, Department of Cancer Medicine, Gustave Roussy Cancer Center, Villejuif, France, discusses updated data with darolutamide in castration-resistant prostate cancer.

x